San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM Ventures, BootstrapLabs, Indie Bio, LaunchCapital and SOSV. Medel.ai will use the capital to forge partnerships with hospitals and cancer genomics companies to bring the system into use.
For $99,...
Medidata, a New York City-based company that offers cloud storage and data analytics services for clinical trials, announced last week its plans to acquire Mytrus, a clinical trial technology company focused on patient-focused electronic informed consent and remote trials. The terms of the acquisition were not disclosed.
“The informed consent process is one of the most important parts of running...
The now-defunct Healogica app.
Clinical trials are a clear area where mobile engagement and big data have serious potential, but it's still a largely untapped use case. There have been a lot of stories recently about the opportunities in that space, but also on the challenges companies have encountered in implementing them. At least one abandoned study and one failed company can attest to those...
